|Articles|March 1, 1996

March 1996
Volume 2
Issue 3

Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project

Author(s)Susan D. Horn, PhD, Phoebe D. Sharkey, PhD, Diane M. Tracy, PhD

Download PDF: Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project

Articles in this issue

over 30 years ago

Article

Managed Care Outcomes Project: Study Design, Baseline Patient Characteristics, and Outcome Measures

over 30 years ago

Article

The National Clinics Research Consortium's (NCRC) Use of Administrative Databases for Collaborative Study: The Case of Prostatectomy

over 30 years ago

Article

Cost-Effectiveness of Chiropractic Care in a Managed Care Setting

over 30 years ago

Article

Can We Continue to Afford Organ Transplants in an Era of Managed Care?

over 30 years ago

Article

The Costs of Allergic Rhinitis

over 30 years ago

Article

PACE: Managed Care for the Frail Elderly

over 30 years ago

Article

Ideas and Initiatives in the Managed Care Marketplace

over 30 years ago

Article

The Impact of Managed Care on Community Psychiatry

over 30 years ago

Article

Managed Care Cost Containment and the Law of Unintended Consequences

over 30 years ago

Article

Correspondence regarding, "Cost Benefit Analysis of Epilepsy Treatment by the Neurologist"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike

United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF

HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD

FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose